Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for IKZF1
Z-value: 2.21
Motif logo
Transcription factors associated with IKZF1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
IKZF1
|
ENSG00000185811.12 | IKAROS family zinc finger 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| IKZF1 | hg19_v2_chr7_+_50348268_50348366 | 0.54 | 2.0e-03 | Click! |
Activity profile of IKZF1 motif
Sorted Z-values of IKZF1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of IKZF1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 12.0 | 72.3 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 4.1 | 16.4 | GO:0006218 | uridine catabolic process(GO:0006218) |
| 3.9 | 31.4 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 3.6 | 10.9 | GO:0015728 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 3.5 | 10.4 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 3.5 | 10.4 | GO:0031662 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 3.0 | 8.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 2.8 | 8.4 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
| 2.8 | 8.4 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 2.7 | 11.0 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 2.7 | 11.0 | GO:0042377 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 2.6 | 7.8 | GO:1904303 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 2.5 | 9.9 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 2.4 | 7.2 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 2.4 | 52.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 2.2 | 8.9 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
| 2.2 | 4.4 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 2.1 | 6.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 2.1 | 6.2 | GO:2000309 | activation of MAPK activity involved in innate immune response(GO:0035419) positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
| 2.0 | 6.0 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 2.0 | 5.9 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 1.9 | 1.9 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
| 1.9 | 15.0 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 1.9 | 5.6 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
| 1.8 | 5.4 | GO:0071790 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 1.8 | 5.3 | GO:0001300 | chronological cell aging(GO:0001300) |
| 1.7 | 3.4 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
| 1.7 | 15.1 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 1.7 | 5.0 | GO:0048627 | myoblast development(GO:0048627) |
| 1.7 | 16.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 1.6 | 6.5 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 1.6 | 4.8 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 1.6 | 1.6 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 1.6 | 4.7 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 1.6 | 9.4 | GO:0035803 | egg coat formation(GO:0035803) |
| 1.5 | 3.0 | GO:0050807 | regulation of synapse organization(GO:0050807) |
| 1.5 | 3.0 | GO:0072034 | renal vesicle induction(GO:0072034) |
| 1.5 | 7.4 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 1.5 | 2.9 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.4 | 5.8 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 1.4 | 1.4 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 1.4 | 7.2 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 1.4 | 4.3 | GO:0070512 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 1.4 | 1.4 | GO:0014013 | regulation of gliogenesis(GO:0014013) |
| 1.4 | 4.2 | GO:1900081 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 1.4 | 5.5 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 1.4 | 9.5 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
| 1.3 | 14.5 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 1.3 | 3.9 | GO:1904172 | regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
| 1.3 | 6.5 | GO:0060356 | leucine import(GO:0060356) |
| 1.3 | 11.4 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 1.3 | 1.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 1.2 | 13.7 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 1.2 | 2.5 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 1.2 | 9.8 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 1.2 | 1.2 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 1.2 | 4.9 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 1.2 | 3.6 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 1.2 | 9.5 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 1.2 | 4.8 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 1.2 | 8.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 1.2 | 1.2 | GO:0007051 | spindle organization(GO:0007051) |
| 1.2 | 7.0 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 1.2 | 6.9 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 1.2 | 1.2 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
| 1.1 | 3.4 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 1.1 | 5.7 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 1.1 | 2.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 1.1 | 2.2 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 1.1 | 1.1 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
| 1.1 | 4.4 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 1.1 | 3.3 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 1.1 | 28.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 1.1 | 3.3 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 1.1 | 13.0 | GO:0009629 | response to gravity(GO:0009629) |
| 1.1 | 6.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 1.1 | 4.2 | GO:0045575 | basophil activation(GO:0045575) |
| 1.1 | 4.2 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 1.1 | 3.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 1.0 | 5.2 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 1.0 | 8.3 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 1.0 | 4.1 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 1.0 | 3.0 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 1.0 | 6.1 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 1.0 | 7.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 1.0 | 1.0 | GO:0042391 | regulation of membrane potential(GO:0042391) |
| 1.0 | 5.0 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 1.0 | 6.0 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
| 1.0 | 12.9 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 1.0 | 4.9 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
| 1.0 | 8.8 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 1.0 | 6.8 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 1.0 | 22.2 | GO:0032060 | bleb assembly(GO:0032060) |
| 1.0 | 2.9 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
| 1.0 | 21.0 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 1.0 | 19.1 | GO:0000022 | mitotic spindle elongation(GO:0000022) |
| 0.9 | 2.8 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.9 | 1.9 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
| 0.9 | 6.6 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.9 | 2.8 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 0.9 | 26.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.9 | 1.8 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.9 | 2.8 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.9 | 3.7 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.9 | 3.7 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.9 | 0.9 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.9 | 9.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.9 | 0.9 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) |
| 0.9 | 1.8 | GO:0046102 | inosine metabolic process(GO:0046102) |
| 0.9 | 1.8 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.9 | 4.4 | GO:0018126 | protein hydroxylation(GO:0018126) peptidyl-proline hydroxylation(GO:0019511) |
| 0.9 | 2.6 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.9 | 2.6 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.9 | 4.3 | GO:1905040 | vestibulocochlear nerve structural organization(GO:0021649) neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) positive regulation of retinal ganglion cell axon guidance(GO:1902336) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.9 | 2.6 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.9 | 2.6 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.9 | 9.5 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.9 | 4.3 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
| 0.8 | 1.7 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.8 | 2.5 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.8 | 5.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.8 | 2.5 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.8 | 2.5 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.8 | 3.3 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.8 | 17.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.8 | 5.7 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 0.8 | 0.8 | GO:0030522 | intracellular receptor signaling pathway(GO:0030522) |
| 0.8 | 4.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.8 | 3.2 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.8 | 2.4 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.8 | 0.8 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.8 | 1.6 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.8 | 2.4 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
| 0.8 | 1.6 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
| 0.8 | 2.3 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 0.8 | 2.3 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 0.8 | 3.8 | GO:1990834 | response to odorant(GO:1990834) |
| 0.8 | 0.8 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.8 | 0.8 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.7 | 5.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.7 | 1.5 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.7 | 3.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.7 | 5.9 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
| 0.7 | 2.2 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.7 | 0.7 | GO:0010888 | negative regulation of lipid storage(GO:0010888) |
| 0.7 | 0.7 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
| 0.7 | 0.7 | GO:1901204 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
| 0.7 | 3.7 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.7 | 3.6 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.7 | 2.9 | GO:0070981 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.7 | 1.4 | GO:0032499 | detection of peptidoglycan(GO:0032499) |
| 0.7 | 2.2 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.7 | 2.2 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.7 | 3.6 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.7 | 2.2 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
| 0.7 | 0.7 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.7 | 3.6 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.7 | 2.1 | GO:0071314 | cellular response to cocaine(GO:0071314) |
| 0.7 | 2.1 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.7 | 6.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.7 | 1.4 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
| 0.7 | 2.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.7 | 2.1 | GO:2001035 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.7 | 2.1 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.7 | 2.1 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.7 | 3.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.7 | 3.5 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.7 | 3.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 0.7 | 0.7 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.7 | 5.5 | GO:0006868 | glutamine transport(GO:0006868) |
| 0.7 | 2.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.7 | 2.7 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.7 | 3.4 | GO:0031337 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.7 | 4.8 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.7 | 2.0 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.7 | 3.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.7 | 4.1 | GO:0071476 | cellular hypotonic response(GO:0071476) |
| 0.7 | 2.0 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
| 0.7 | 1.3 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.7 | 2.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.7 | 4.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.7 | 82.8 | GO:0070268 | cornification(GO:0070268) |
| 0.7 | 4.7 | GO:0070305 | response to cGMP(GO:0070305) |
| 0.7 | 2.0 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.7 | 4.0 | GO:0032252 | secretory granule localization(GO:0032252) |
| 0.7 | 2.0 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.7 | 5.3 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.7 | 0.7 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.7 | 3.3 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.7 | 2.0 | GO:0097254 | renal tubular secretion(GO:0097254) |
| 0.6 | 3.9 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.6 | 1.9 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.6 | 0.6 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
| 0.6 | 2.6 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.6 | 1.3 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 0.6 | 1.9 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.6 | 12.0 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.6 | 2.5 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
| 0.6 | 1.9 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.6 | 3.1 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.6 | 0.6 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.6 | 3.1 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.6 | 1.8 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.6 | 0.6 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.6 | 2.5 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.6 | 0.6 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
| 0.6 | 3.7 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.6 | 2.4 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.6 | 0.6 | GO:1903923 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 0.6 | 1.8 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.6 | 1.8 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
| 0.6 | 2.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.6 | 2.4 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.6 | 3.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.6 | 6.6 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.6 | 0.6 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.6 | 2.4 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.6 | 3.6 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.6 | 0.6 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
| 0.6 | 0.6 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.6 | 2.9 | GO:0070384 | Harderian gland development(GO:0070384) |
| 0.6 | 0.6 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 0.6 | 0.6 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.6 | 2.3 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.6 | 3.5 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.6 | 1.7 | GO:1904640 | response to methionine(GO:1904640) |
| 0.6 | 1.7 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.6 | 3.5 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.6 | 0.6 | GO:0044848 | biological phase(GO:0044848) |
| 0.6 | 1.7 | GO:1905166 | negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.6 | 2.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.6 | 1.7 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.6 | 3.4 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.6 | 6.3 | GO:0070141 | response to UV-A(GO:0070141) |
| 0.6 | 2.3 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
| 0.6 | 3.4 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
| 0.6 | 2.3 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.6 | 1.7 | GO:1904387 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.6 | 1.7 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.6 | 0.6 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.6 | 1.7 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.6 | 2.2 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.6 | 1.1 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.6 | 0.6 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.6 | 2.2 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.6 | 0.6 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.6 | 2.8 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.6 | 3.9 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
| 0.6 | 12.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
| 0.6 | 5.5 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
| 0.6 | 2.8 | GO:0007418 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 0.5 | 0.5 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 0.5 | 0.5 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
| 0.5 | 4.9 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.5 | 1.6 | GO:0035565 | regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
| 0.5 | 1.6 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 0.5 | 3.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.5 | 1.1 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 0.5 | 0.5 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.5 | 5.4 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.5 | 1.6 | GO:1901994 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.5 | 2.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.5 | 0.5 | GO:1904030 | negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.5 | 1.6 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
| 0.5 | 3.2 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.5 | 1.6 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.5 | 5.8 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
| 0.5 | 2.1 | GO:0060694 | regulation of cholesterol transporter activity(GO:0060694) response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.5 | 1.6 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
| 0.5 | 2.1 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 0.5 | 0.5 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 0.5 | 1.0 | GO:0035854 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.5 | 0.5 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.5 | 1.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.5 | 4.1 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.5 | 4.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.5 | 2.1 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.5 | 2.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.5 | 1.0 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.5 | 2.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.5 | 1.5 | GO:1903925 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.5 | 4.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.5 | 1.0 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 0.5 | 5.6 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.5 | 1.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.5 | 1.5 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
| 0.5 | 1.0 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.5 | 1.5 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 0.5 | 4.0 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
| 0.5 | 4.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.5 | 1.5 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.5 | 7.3 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
| 0.5 | 3.4 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.5 | 1.5 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.5 | 4.4 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
| 0.5 | 0.5 | GO:0002585 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.5 | 1.9 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.5 | 2.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.5 | 5.8 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.5 | 1.0 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.5 | 1.0 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.5 | 4.3 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.5 | 2.9 | GO:0014028 | notochord formation(GO:0014028) |
| 0.5 | 1.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.5 | 2.4 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.5 | 7.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.5 | 8.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.5 | 3.8 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.5 | 6.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.5 | 0.9 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.5 | 2.3 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.5 | 0.5 | GO:0003231 | cardiac ventricle development(GO:0003231) |
| 0.5 | 9.8 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.5 | 2.3 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.5 | 0.9 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
| 0.5 | 2.3 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.5 | 0.5 | GO:0001523 | retinoid metabolic process(GO:0001523) |
| 0.5 | 1.4 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.5 | 0.5 | GO:0043103 | hypoxanthine salvage(GO:0043103) |
| 0.5 | 5.5 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.5 | 0.9 | GO:0030278 | regulation of ossification(GO:0030278) |
| 0.5 | 1.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.5 | 1.4 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.5 | 3.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.5 | 0.9 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
| 0.5 | 2.3 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.4 | 0.9 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
| 0.4 | 0.4 | GO:0033189 | response to vitamin A(GO:0033189) |
| 0.4 | 5.8 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.4 | 2.2 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
| 0.4 | 2.7 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.4 | 1.3 | GO:0003383 | apical constriction(GO:0003383) |
| 0.4 | 4.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.4 | 1.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.4 | 1.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.4 | 5.7 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.4 | 0.9 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
| 0.4 | 1.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.4 | 1.3 | GO:0042214 | terpene metabolic process(GO:0042214) |
| 0.4 | 0.9 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.4 | 0.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.4 | 2.6 | GO:1901906 | diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.4 | 1.7 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.4 | 1.3 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.4 | 0.9 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.4 | 3.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.4 | 2.1 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.4 | 6.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.4 | 4.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.4 | 0.4 | GO:0071878 | negative regulation of adrenergic receptor signaling pathway(GO:0071878) |
| 0.4 | 3.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
| 0.4 | 1.3 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.4 | 3.3 | GO:0046618 | drug export(GO:0046618) |
| 0.4 | 1.3 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.4 | 1.3 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 0.4 | 1.7 | GO:0051775 | response to redox state(GO:0051775) |
| 0.4 | 0.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.4 | 0.4 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
| 0.4 | 1.6 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.4 | 6.6 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.4 | 10.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.4 | 2.1 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.4 | 1.2 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.4 | 6.1 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.4 | 2.0 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 0.4 | 0.8 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) |
| 0.4 | 5.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.4 | 2.8 | GO:0090009 | primitive streak formation(GO:0090009) |
| 0.4 | 6.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.4 | 7.2 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.4 | 0.8 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.4 | 1.2 | GO:0030070 | insulin processing(GO:0030070) |
| 0.4 | 5.6 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.4 | 9.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
| 0.4 | 0.8 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.4 | 2.8 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.4 | 6.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.4 | 2.0 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.4 | 5.5 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.4 | 2.0 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 0.4 | 2.0 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
| 0.4 | 0.4 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
| 0.4 | 2.7 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.4 | 1.6 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 0.4 | 2.0 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.4 | 3.1 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
| 0.4 | 1.6 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.4 | 1.2 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 0.4 | 2.3 |